Canola oil may tame metabolic syndrome, study hints
NCT ID NCT01890330
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether eating canola oil every day for 12 weeks can improve cholesterol, blood vessel function, and other risk factors in people with metabolic syndrome. Eighty adults with the condition were randomly assigned to consume either canola oil or a typical Western fat blend. Researchers measured changes in blood fats and artery health to see if canola oil offers any advantage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Canola oil
What this could lead to
If it works, this could point toward a simple dietary change to help manage metabolic syndrome and reduce heart disease risk.
What could go wrong
This is a small, early-stage dietary study with only 80 participants. Results may not apply to everyone, and any benefits are likely modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Boniface General Hospital - I.H. Asper Clinical Research Institute
Winnipeg, Manitoba, R2H 2A6, Canada